Details of the Drug Formulaction

General Information of Drug Formulation (ID: F09616)

• Formulation Name: Hydralazine 50 mg tablet
• Company: Aidarex Pharmaceuticals; American Health Packaging; Aphena Pharma Solutions-Tennessee; Clinical Solutions Wholesale; Contract Pharmacal; Heritage Pharmaceuticals; Major Pharmaceuticals; NuCare Pharmaceuticals; PD-Rx Pharmaceuticals; Physicians Total Care; RemedyRepack; St Marys Medical Park Pharmacy

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Hydralazine	(DMU8JGH)	Chronic heart failure	BD1Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent